Rovituso, Damiano, Heller, Stefanie, Schroeter, Michael, Kleinschnitz, Christoph ORCID: 0000-0002-1650-8875 and Kuerten, Stefanie (2014). B1 cells are unaffected by immune modulatory treatment in remitting-relapsing multiple sclerosis patients. J. Neuroimmunol., 272 (1-2). S. 86 - 91. AMSTERDAM: ELSEVIER SCIENCE BV. ISSN 1872-8421

Full text not available from this repository.

Abstract

In this study we aimed to investigate whether treatment with an immune modulatory drug had an effect on the distribution of B cell subpopulations in patients with remitting-relapsing multiple sclerosis (RRMS). We investigated the first-line drugs glatiramer acetate, interferon-beta and natalizumab. Our data show that the frequency of the CD27(+)CD43(+) B1 cell subset was significantly diminished in RRMS patients compared to healthy subjects and that this subset was unaffected by treatment. Regardless of their true nature, we believe that these cells are part of the autoimmune disease pattern. (C) 2014 Elsevier B.V. All rights reserved.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Rovituso, DamianoUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Heller, StefanieUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schroeter, MichaelUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kleinschnitz, ChristophUNSPECIFIEDorcid.org/0000-0002-1650-8875UNSPECIFIED
Kuerten, StefanieUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-433871
DOI: 10.1016/j.jneuroim.2014.04.008
Journal or Publication Title: J. Neuroimmunol.
Volume: 272
Number: 1-2
Page Range: S. 86 - 91
Date: 2014
Publisher: ELSEVIER SCIENCE BV
Place of Publication: AMSTERDAM
ISSN: 1872-8421
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
MEMORY; SUBPOPULATIONMultiple languages
Immunology; NeurosciencesMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/43387

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item